Wholesale Tamoxifen Citrate Tablet IP Supplier
Safety Information
Tamoxifen Citrate Tablet IP is a prescription medicine used in the management of certain hormone-sensitive breast cancers. It should be used only under appropriate medical supervision and according to applicable prescribing information.
Important safety considerations include:
Blood Clots: Tamoxifen may increase the risk of venous thromboembolic events. Patients should seek medical attention for symptoms such as unexplained leg swelling, chest pain, or sudden shortness of breath.
Uterine Effects: Tamoxifen has been associated with changes in the uterus, including endometrial abnormalities. Appropriate medical evaluation is important for unusual vaginal bleeding or other concerning symptoms.
Liver Function: Liver-related effects may occur, and appropriate clinical assessment should be considered where medically indicated.
Menstrual & Reproductive Effects: Tamoxifen can affect menstrual cycles and reproductive function.
Vision: Visual disturbances, including cataract-related changes, may occur and should be medically evaluated.
Drug Interactions: Other medicines, particularly medicines that affect CYP2D6 or estrogen activity, should be reviewed by a qualified healthcare professional.
Pregnancy: Tamoxifen should not be used during pregnancy unless specifically directed by an appropriate specialist; pregnancy-related precautions should be discussed with a healthcare professional.
Breastfeeding: Breastfeeding considerations should be discussed with an appropriate healthcare professional.
Professional Guidance: Dose, treatment duration, monitoring, and any treatment adjustments should follow applicable prescribing information and qualified medical instructions.
Benefits of Tamoxifen Citrate Tablet IP
Hormonal Therapy
Tamoxifen is a selective estrogen receptor modulator (SERM) used in the treatment of appropriate hormone-receptor-positive breast cancer and in other clinically indicated settings.
Supports Management of Hormone-Sensitive Breast Cancer
The medicine may be used as part of an appropriate treatment plan to reduce the effects of estrogen on susceptible breast cancer cells.
Oral Pharmaceutical Formulation
Tamoxifen Citrate is supplied as an oral tablet formulation, providing a convenient dosage presentation for patients prescribed tamoxifen.
Professional Clinical Application
Its use is relevant to oncology and breast-cancer treatment settings where tamoxifen therapy is medically indicated.
Tablet IP Presentation
The IP-compliant presentation can be considered for pharmaceutical procurement requirements according to the applicable product registration, market authorization, and prescribing requirements.
These are characteristics and potential clinical benefits of tamoxifen; they do not guarantee an individual treatment outcome.
What to Include in Your Request for Quotation
Product: Tamoxifen Citrate Tablet IP
Active Ingredient: Tamoxifen Citrate
Strength: Required strength/presentation
Quantity: Required tablets/boxes
Destination: International destination as applicable
Buyer Type: Distributor / Importer / Wholesaler / Institution
Required Shelf Life: Specify minimum remaining shelf life if applicable
Documents Needed: List mandatory product, quality, regulatory, and export documentation
Pack Requirement: Specify pack size or packaging requirements if applicable
This information helps match the proposed supply to the actual pharmaceutical procurement requirement.
Important Precautions Before Administration
Current or previous blood-clotting disorders
History of stroke or thromboembolic events
Unusual vaginal bleeding or uterine abnormalities
Liver-related medical conditions
Vision or eye problems
Pregnancy or plans for pregnancy
Breastfeeding
Other medicines and potential drug interactions
Any existing medical conditions
Previous reactions to tamoxifen or related medicines
Storage of Tamoxifen Citrate Tablets IP
For pharmaceutical wholesalers and distributors, storage should be based on the exact instructions provided on the supplied product's label and manufacturer documentation.
Maintain Specified Storage Conditions
Warehouse conditions should remain within the temperature, humidity, light, and environmental range required by the product labeling.
Retain Original Packaging
Keep stock in its original packaging to protect product identification, labeling, and product integrity.
Maintain Batch Traceability
Each received batch should remain traceable through appropriate inventory and distribution records.
Monitor Expiry Dates
Expiry dates and remaining shelf life should be actively monitored throughout warehousing and distribution.
Protect Packaging Integrity
Damaged, opened, or compromised pharmaceutical packs should be segregated and evaluated appropriately.
Secure Pharmaceutical Storage
